BIOBANKING Market Key Players: ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions, Inc.

A fresh report titled “BIOBANKING Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for BIOBANKING Market. The competition analysis is also a major part of the report.

Biobank is a biorepository meant to collect and preserve biological materials that are used for diagnosis, biodiversity studies, and research. In addition, it is used to support the research of most common types of genetic disorders to develop personalized medicines and to maintain and update age demographic databases.

Request for Sample @ https://www.kdmarketinsights.com/sample/4111

The global biobanking market garnered $47,062 million in 2016, and is estimated to reach $68,084 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples are the major factors that drive the growth of the global biobanking market. Moreover, upsurge in incidence of diseases such as cancer supports the market growth, owing to the fact that biobanked specimens are used in the treatment of several chronic diseases. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. On the contrary, advancements in stem cell research and unmet medical needs in the emerging nations are anticipated to provide lucrative opportunity for the market expansion.

The global biobanking market is segmented by specimen type, type of biobank, ownership, application, and region. Based on specimen type, the market is categorized into blood products, solid tissue, cell lines, and others. On the basis of ownership, it is divided into national/regional agencies, nonprofit organization, university, and private. The applications covered in the study include therapeutic and research. Depending on type of biobank, the market is bifurcated into population and disease-oriented biobank. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS
- This report provides an extensive analysis of the current and emerging trends and dynamics in the globalbiobanking market to identify the prevailing opportunities.
- It presents a competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS
By Specimen Type
- Blood products
- Solid tissue
- Cell lines
- Others

By Application
- Therapeutic
- Research

By Type of Biobank
- Population-based biobanks
- Disease-oriented biobanks

By Ownership
- National/regional agencies
- Nonprofit organization
- University
- Private

By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

The key players profiled in this report are as follows:
- ASKION GmbH
- CTI BIOTECH
- Cureline, Inc.
- Excilone SARL
- Firalis S.A.
- Hamilton Company
- LabVantage Solutions, Inc.
- LGC Limited
- PrecisionMed, Inc.
- ProMedDx LLC

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/biobanking-market-amr

Table of Content

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in funds for biobanks
3.4.1.2. Increase in R&D activities for application of biobank specimens
3.4.1.3. Surge in prevalence of fatal chronic diseases
3.4.2. Restraints
3.4.2.1. Legal and ethical issues
3.4.2.2. Lack of awareness regarding biobanking
3.4.3. Opportunity
3.4.3.1. Untapped opportunities in the developing regions
3.4.4. Impact analyses

CHAPTER 4: BIOBANKING MARKET, BY SPECIMEN TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Blood products
4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country
4.3. Solid tissues
4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country
4.4. Cell lines
4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country
4.5. Others
4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country

CHAPTER 5: BIOBANKING MARKET, BY TYPE OF BIOBANK
5.1. Overview
5.1.1. Market size and forecast
5.2. Population-based biobanks
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Disease-oriented biobanks
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: BIOBANKING MARKET, BY OWNERSHIP
6.1. Overview
6.1.1. Market size and forecast
6.2. National/regional agencies
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Nonprofit organization
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. University
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Private organization
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

CHAPTER 7: BIOBANKING MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Therapeutic
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Research
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/4111

Contact Us
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com

About KD Market Insights
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.